Comment on: Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort

J Antimicrob Chemother. 2014 Nov;69(11):3167. doi: 10.1093/jac/dku301. Epub 2014 Aug 6.

Authors

Oguz Karabay¹, Ayse Batirel², Ilker Inanc Balkan³

Affiliations

¹ Infectious Diseases and Clinical Microbiology, Medical Faculty, Sakarya University, Sakarya, Turkey.
² Infectious Diseases and Clinical Microbiology, Kartal Dr. Lutfi Kirdar Education and Research Hospital, Istanbul, Turkey [email protected].
³ Infectious Diseases and Clinical Microbiology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.

PMID: 25103490
DOI: 10.1093/jac/dku301

No abstract available

Keywords: A. baumannii; MDR; MDRAB.

Publication types

Letter
Comment

MeSH terms

Acinetobacter Infections / drug therapy*
Acinetobacter baumannii / isolation & purification*
Anti-Bacterial Agents / administration & dosage*
Drug Resistance, Multiple, Bacterial / drug effects*
Female
Humans
Male
Sepsis / drug therapy*

Substances

Anti-Bacterial Agents